Vertex Pharmaceuticals Statistics

Total Valuation

LON:0QZU has a market cap or net worth of GBP 74.81 billion. The enterprise value is 67.07 billion.

Market Cap	74.81B
Enterprise Value	67.07B

Important Dates

The last earnings date was Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	256.39M
Shares Outstanding	n/a
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	-0.23%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	255.59M

Valuation Ratios

The trailing PE ratio is 28.17 and the forward PE ratio is 19.90.

PE Ratio	28.17
Forward PE	19.90
PS Ratio	8.98
PB Ratio	5.97
P/TBV Ratio	6.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.29, with an EV/FCF ratio of 26.26.

EV / Earnings	25.26
EV / Sales	7.97
EV / EBITDA	18.29
EV / EBIT	19.67
EV / FCF	26.26

Financial Position

The company has a current ratio of 2.52, with a Debt / Equity ratio of 0.09.

Current Ratio	2.52
Quick Ratio	2.00
Debt / Equity	0.09
Debt / EBITDA	0.31
Debt / FCF	0.44
Interest Coverage	272.16

Financial Efficiency

Return on equity (ROE) is 22.77% and return on invested capital (ROIC) is 16.81%.

Return on Equity (ROE)	22.77%
Return on Assets (ROA)	13.09%
Return on Invested Capital (ROIC)	16.81%
Return on Capital Employed (ROCE)	23.25%
Revenue Per Employee	1.37M
Profits Per Employee	435,260
Employee Count	6,100
Asset Turnover	0.52
Inventory Turnover	4.17

Taxes

In the past 12 months, LON:0QZU has paid 537.50 million in taxes.

Income Tax	537.50M
Effective Tax Rate	16.84%

Stock Price Statistics

The stock price has decreased by -15.12% in the last 52 weeks. The beta is 0.44, so LON:0QZU's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-15.12%
50-Day Moving Average	447.75
200-Day Moving Average	460.26
Relative Strength Index (RSI)	35.75
Average Volume (20 Days)	1,033

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.66

Income Statement

In the last 12 months, LON:0QZU had revenue of GBP 8.33 billion and earned 2.66 billion in profits. Earnings per share was 10.27.

Revenue	8.33B
Gross Profit	4.66B
Operating Income	3.38B
Pretax Income	3.19B
Net Income	2.66B
EBITDA	3.50B
EBIT	3.38B
Earnings Per Share (EPS)	10.27

Full Income Statement

Balance Sheet

The company has 4.66 billion in cash and 1.11 billion in debt, giving a net cash position of 7.66 billion.

Cash & Cash Equivalents	4.66B
Total Debt	1.11B
Net Cash	7.66B
Net Cash Per Share	n/a
Equity (Book Value)	12.54B
Book Value Per Share	48.91
Working Capital	4.59B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.81 billion and capital expenditures -253.06 million, giving a free cash flow of 2.55 billion.

Operating Cash Flow	2.81B
Capital Expenditures	-253.06M
Free Cash Flow	2.55B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 55.91%, with operating and profit margins of 40.52% and 31.86%.

Gross Margin	55.91%
Operating Margin	40.52%
Pretax Margin	38.31%
Profit Margin	31.86%
EBITDA Margin	42.05%
EBIT Margin	40.52%
FCF Margin	30.65%

Dividends & Yields

LON:0QZU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.19%
Shareholder Yield	n/a
Earnings Yield	3.55%
FCF Yield	3.41%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0QZU has an Altman Z-Score of 12.61 and a Piotroski F-Score of 5.

Altman Z-Score	12.61
Piotroski F-Score	5